Diabetic Foot Ulcers (DFUs)
0
Pipeline Programs
2
Companies
3
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
RB
Reprise BiomedicalMN - Plymouth
2 programsAcellular Porcine-Derived Wound MatrixN/A1 trial
Miro3D Wound MatrixN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
ConvaTecConvaNiox
Reprise BiomedicalMiro3D Wound Matrix
Reprise BiomedicalAcellular Porcine-Derived Wound Matrix
Clinical Trials (3)
An Observational, Real World Evidence Study on the Efficacy and Safety of a Nitric Oxide Generating Dressing in the Treatment of Diabetes Related Foot Ulcers.
Start: Jul 2026Est. completion: Sep 2027
N/ANot Yet Recruiting
Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing
Start: Nov 2024Est. completion: Jul 2026
N/ARecruiting
Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care
Start: Feb 2024Est. completion: Dec 2025
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials
2 companies competing in this space